NYSE - Delayed Quote • USD
CVS Health Corporation (CVS)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 26 | 25 |
| Avg. Estimate | 1.71 | 2.21 | 8.3 | 9.16 |
| Low Estimate | 1.63 | 1.94 | 8.11 | 8.9 |
| High Estimate | 2.02 | 2.34 | 8.4 | 9.53 |
| Year Ago EPS | 2.2 | 2.21 | 8.74 | 8.3 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 23 | 23 |
| Avg. Estimate | 89.2B | 92.08B | 370.82B | 392.61B |
| Low Estimate | 87.42B | 90.01B | 363.6B | 384.03B |
| High Estimate | 91.18B | 93.49B | 377.36B | 401.28B |
| Year Ago Sales | 80.81B | 88.92B | 357.78B | 370.82B |
| Sales Growth (year/est) | 10.40% | 3.60% | 3.60% | 5.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2.09 | 2.11 | 2.13 | 1.99 |
| EPS Actual | 2.2 | 2.21 | 2.21 | 2.12 |
| Difference | 0.11 | 0.1 | 0.08 | 0.13 |
| Surprise % | 5.30% | 4.70% | 3.80% | 6.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.71 | 2.21 | 8.3 | 9.16 |
| 7 Days Ago | 1.71 | 2.21 | 8.3 | 9.17 |
| 30 Days Ago | 1.71 | 2.22 | 8.31 | 9.22 |
| 60 Days Ago | 1.73 | 2.2 | 8.32 | 9.22 |
| 90 Days Ago | 1.86 | 2.03 | 7.83 | 8.61 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | 1 | 1 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 2 | 2 |
Growth Estimates
| CURRENCY IN USD | CVS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -22.30% | -- | -- | 6.50% |
| Next Qtr. | 0.00% | -- | -- | 12.00% |
| Current Year | -5.00% | -- | -- | 5.30% |
| Next Year | 10.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 3.69% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 4.31% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/10/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/8/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 4/4/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 3/15/2024 |
| Initiated | Barclays: Equal-Weight | 3/6/2024 |
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
Related Tickers
UNH UnitedHealth Group Incorporated
495.35
+0.30%
HUM Humana Inc.
305.90
-1.77%
CI The Cigna Group
354.47
-0.01%
ELV Elevance Health, Inc.
537.26
-0.45%
CNC Centene Corporation
74.00
-2.22%
MOH Molina Healthcare, Inc.
342.23
-2.86%
OSCR Oscar Health, Inc.
17.56
-1.84%
CLOV Clover Health Investments, Corp.
0.6800
+1.49%
ALHC Alignment Healthcare, Inc.
5.21
+0.97%
NEUE NeueHealth, Inc.
6.11
-3.54%